Skip to main content
VCbacked
Log inGet Started

Nuage Therapeutics

Barcelona, Spain

Nuage Therapeutics engages in developing drugs which target proteins in disordered regions for challenging indications faced by patients.

$12.9M raised
Mar 2023
Seed
BiopharmaBiotechnologyLife SciencePharmaceutical

Top Investors

Sofinnova PartnersAsabys PartnersCentre for the Development of Industrial Technology (CDTI)BStartup - Banc Sabadell

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Nuage Therapeutics

How much funding has Nuage Therapeutics raised?
Nuage Therapeutics has raised $12.9M in total funding. The most recent round was Seed. The last funding was announced in March 2023.
Who are Nuage Therapeutics's investors?
Nuage Therapeutics's investors include Sofinnova Partners, Asabys Partners, Centre for the Development of Industrial Technology (CDTI), BStartup - Banc Sabadell.
Where is Nuage Therapeutics headquartered?
Nuage Therapeutics is headquartered in Barcelona, Spain.
What does Nuage Therapeutics do?
Nuage Therapeutics engages in developing drugs which target proteins in disordered regions for challenging indications faced by patients.
What stage is Nuage Therapeutics at?
Nuage Therapeutics is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Nuage Therapeutics — Funding & Investors." VCBacked, March 14, 2023, https://www.vcbacked.co/company/nuage-therapeutics. Accessed July 3, 2026.
APA
VCBacked. (2023). Nuage Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/nuage-therapeutics
Wikipedia (cite web)
{{cite web |title=Nuage Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/nuage-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
Allterum Therapeutics
Houston$1.0M
Epsilogen
London$16.3M
Cairn Therapeutics
Tucson$3.0M
Living In Silico Inc.
Brampton$3K
KuriBio
Berkeley$150K
Systemic Bio
Houston$15.0M